Table 3 Multiple regression analysis results on anti-SARS-CoV-2 IgG APR and Ab levels
From: IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients
Variables | anti-SARS-CoV-2 IgG APR | anti-SARS-CoV-2 IgG Ab levels | ||
|---|---|---|---|---|
Exp (B) (95% confidence interval) | P-value | B value (95% confidence interval) | P-value | |
Anti-CD20 times | 0.795 (0.669 ~ 0.946) | 0.009 | -0.232 (-0.414 ~ -0.051) | 0.01 |
ASCT | 0.057 (0.007 ~ 0.445) | 0.006 | -1.746 (-3.998 ~ 0.505) | 0.13 |
B (CD19+) cell count (103/µL) | 1.000013 (0.999998 ~ 1.000028) | 0.09 | -0.547 × 10− 6 (-8.851 × 10− 6 ~ 7.757 × 10− 6) | 0.90 |
vaccination history | 0.993 (0.190 ~ 5.175) | 0.99 | 1.125 (-0.957 ~ 3.207) | 0.29 |
Treatment for COVID-19 with dexamethasone | 0.954 (0.133 ~ 6.873) | 0.96 | -2.005 (-4.557 ~ 0.546) | 0.12 |